1. Home
  2. KMT vs AKRO Comparison

KMT vs AKRO Comparison

Compare KMT & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMT
  • AKRO
  • Stock Information
  • Founded
  • KMT 1938
  • AKRO 2017
  • Country
  • KMT United States
  • AKRO United States
  • Employees
  • KMT N/A
  • AKRO N/A
  • Industry
  • KMT Industrial Machinery/Components
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KMT Industrials
  • AKRO Health Care
  • Exchange
  • KMT Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • KMT 2.0B
  • AKRO 2.1B
  • IPO Year
  • KMT N/A
  • AKRO 2019
  • Fundamental
  • Price
  • KMT $29.19
  • AKRO $35.15
  • Analyst Decision
  • KMT Hold
  • AKRO Strong Buy
  • Analyst Count
  • KMT 5
  • AKRO 7
  • Target Price
  • KMT $24.60
  • AKRO $43.20
  • AVG Volume (30 Days)
  • KMT 1.0M
  • AKRO 538.4K
  • Earning Date
  • KMT 11-06-2024
  • AKRO 11-15-2024
  • Dividend Yield
  • KMT 2.73%
  • AKRO N/A
  • EPS Growth
  • KMT N/A
  • AKRO N/A
  • EPS
  • KMT 1.28
  • AKRO N/A
  • Revenue
  • KMT $2,036,371,000.00
  • AKRO N/A
  • Revenue This Year
  • KMT $0.69
  • AKRO N/A
  • Revenue Next Year
  • KMT $2.62
  • AKRO N/A
  • P/E Ratio
  • KMT $22.93
  • AKRO N/A
  • Revenue Growth
  • KMT N/A
  • AKRO N/A
  • 52 Week Low
  • KMT $22.44
  • AKRO $13.39
  • 52 Week High
  • KMT $32.18
  • AKRO $37.00
  • Technical
  • Relative Strength Index (RSI)
  • KMT 81.13
  • AKRO 72.72
  • Support Level
  • KMT $24.96
  • AKRO $31.12
  • Resistance Level
  • KMT $32.18
  • AKRO $32.95
  • Average True Range (ATR)
  • KMT 0.82
  • AKRO 1.56
  • MACD
  • KMT 0.59
  • AKRO 0.37
  • Stochastic Oscillator
  • KMT 84.62
  • AKRO 94.19

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: